Cue Biopharma Inc. (CUE)
1.21
-0.02 (-1.63%)
At close: Mar 03, 2025, 3:59 PM
1.20
-0.41%
After-hours: Mar 03, 2025, 04:00 PM EST
Cue Biopharma Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 48.51M | 51.61M | 64.37M | 74.87M | 44.29M | 20.8M | 63.53M | 14.93M | 6.41M |
| Short-Term Investments | n/a | 24.67M | n/a | 10M | 15.12M | 18.41M | 50.07K | 50.03K | 50K |
| Long-Term Investments | 151K | 150K | 150K | 150K | 150K | 150K | n/a | n/a | n/a |
| Other Long-Term Assets | 2.81M | 3.24M | 2.86M | 2.97M | 3.4M | 1.82M | 23.28K | 117K | 98.5K |
| Receivables | 1.7M | 57.25K | 3.14M | 1.42M | 754.9K | n/a | n/a | n/a | n/a |
| Inventory | n/a | 1.00 | 1.00 | n/a | 15.12M | n/a | 225.5K | n/a | n/a |
| Other Current Assets | 1.24M | 1.68M | 1.83M | 2.48M | 1.72M | 1.4M | 1.31M | 162.4K | 51.45K |
| Total Current Assets | 51.45M | 77.19M | 68.47M | 87.53M | 61.02M | 40.61M | 65.07M | 15.14M | 6.51M |
| Property-Plant & Equipment | 7.12M | 10.7M | 11.92M | 8.88M | 7.18M | 2.78M | 1.69M | 1.02M | 709.47K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | 11.67K | n/a | 175K | n/a | n/a |
| Total Long-Term Assets | 10.08M | 14.1M | 14.93M | 12.01M | 10.58M | 4.75M | 1.89M | 1.14M | 807.97K |
| Total Assets | 61.53M | 91.28M | 83.4M | 99.53M | 71.61M | 45.36M | 66.95M | 16.28M | 7.31M |
| Account Payables | 3.5M | 2.73M | 2.59M | 2.07M | 882.67K | 2.04M | 1.33M | 523.81K | 139.63K |
| Deferred Revenue | 2.11M | n/a | 645.35K | 6.68M | 4.1M | 2.01M | 623.85K | n/a | n/a |
| Short-Term Debt | 7.33M | 5.26M | 9.86M | 9.55M | 8.9M | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 4.14M | 3.55M | 333.63K | -1.99M | -2.22M | 2.17M | 4.02M | 543.8K | 202.57K |
| Total Current Liabilities | 17.08M | 11.55M | 12.79M | 16.32M | 11.66M | 6.22M | 5.35M | 1.07M | 342.2K |
| Long-Term Debt | 7.36M | 14.06B | 5.12M | 2.37M | 1.35M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | -14.04B | n/a | n/a | n/a | n/a | n/a | 36.36K | 34.09K |
| Total Long-Term Liabilities | 7.36M | 14.05M | 5.12M | 4.31M | 5.37M | 5.17M | n/a | 36.36K | 34.09K |
| Total Liabilities | 24.45M | 25.6M | 17.91M | 20.62M | 17.02M | 11.39M | 5.35M | 1.1M | 376.3K |
| Total Debt | 14.7M | 19.32M | 10.05M | 7.15M | 5.8M | n/a | 2.5M | n/a | n/a |
| Common Stock | 47K | 43.04K | 32.2K | 30.35K | 26.56K | 20.7K | 20.13K | 10.64K | 7.35K |
| Retained Earnings | -301.19M | -250.46M | -197.45M | -153.29M | -108.5M | -71.8M | -32.82M | -9.59M | -1.93M |
| Comprehensive Income | n/a | -95.87K | -0.00 | 7.13K | -10.32K | -10.96K | -661.15K | -246.9K | -44.81K |
| Shareholders Equity | 37.09M | 65.68M | 65.49M | 78.91M | 54.58M | 33.97M | 61.61M | 15.17M | 6.94M |
| Total Investments | 151K | 24.67M | 150K | 10M | 15.12M | 18.41M | 50.07K | 50.03K | 50K |